
[Federal Register: May 18, 2010 (Volume 75, Number 95)]
[Proposed Rules]               
[Page 27672]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18my10-16]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1140

[Docket No. FDA-2010-N-0136]
RIN 0910-AG33

 
Request for Comment on Implementation of the Family Smoking 
Prevention and Tobacco Control Act; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Advance notice of proposed rulemaking; extension of comment 
period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is extending for 60 
days the comment period for the advance notice of proposed rulemaking 
(ANPRM) that appeared in the Federal Register of March 19, 2010. In the 
ANPRM, FDA requested comments, data, research, or other information on 
the regulation of outdoor advertising of cigarettes and smokeless 
tobacco. The agency is taking this action in response to a request for 
an extension to allow interested persons additional time to submit 
comments.

DATES: The comment period for the advance notice of proposed 
rulemaking, published March 19, 2010, at 75 FR 13241, is extended. 
Submit electronic or written comments by July 19, 2010.

ADDRESSES: You may submit comments, identified by Docket No FDA-2010-N-
0136 and/or RIN number 0910-AG33, by any of the following methods:
Electronic Submissions
    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
Written Submissions
    Submit written submissions in the following ways:
     FAX: 301-827-6870.
     Mail/Hand delivery/Courier (for paper, disk, or CD-ROM 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
    Instructions: All submissions received must include the agency name 
and docket number and Regulatory Information Number (RIN) for this 
rulemaking. All comments received may be posted without change to 
http://www.regulations.gov, including any personal information 
provided. For additional information on submitting comments, see the 
``Comments'' heading of the SUPPLEMENTARY INFORMATION section of this 
document.
    Docket: For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov and insert the 
docket number, found in brackets in the heading of this document, into 
the ``Search'' box and follow the prompts and/or go to the Division of 
Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Annette Marthaler, Center for Tobacco 
Products, Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850-3229, 1-877-287-1373, 
annette.marthaler@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    In the Federal Register of March 19, 2010 (75 FR 13241), FDA 
published an ANPRM with a 60-day comment period to request data, 
research, information, and comments on whether restrictions on outdoor 
advertising of tobacco products are necessary to protect children and 
adolescents from the harms caused by tobacco use and, if they are, 
whether the restrictions under consideration (as identified in the 
ANPRM), or close variations would be justified, lawful, and 
appropriate. FDA also solicited data, research, information, and 
comments on other restrictions on outdoor advertising that, either in 
addition to or instead of the specific restrictions under 
consideration, would advance the public health goal of protecting 
children and adolescents from the harms caused by tobacco use.
    The agency has received a request for a 90-day extension of the 
comment period for the ANPRM. The request conveyed concern that the 
current 60-day comment period does not allow sufficient time to develop 
a meaningful response to the ANPRM.
    FDA has considered the request and is extending the comment period 
for the ANPRM for 60 days, until July 19, 2010. The agency believes 
that a 60-day extension allows adequate time for interested persons to 
submit comments without significantly delaying a rulemaking on this 
important issue.

II. Comments

    Interested persons may submit to the Division of Dockets Management 
(see ADDRESSES) either electronic or written comments regarding this 
document. it is only necessary to send one set of comments. It is no 
longer necessary to send two copies of mailed comments. Identify 
comments with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Division of Dockets 
Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: May 13, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-11799 Filed 5-17-10; 8:45 am]
BILLING CODE 4160-01-S

